 less
than 80 years as long as the expected combined stroke
and mortality risk for the surgeon was not more than 3%.
The long-term effectiveness of CEA in asymptomatic
patients was conÔ¨Årmed by ACST I, as reported by Halliday et al194 compared with patients randomized to the
medical arm which primarily involved antithrombotic
and antihypertensive therapy, patients aged less than
75 years in the CEA arm